“DIABETIC KETOACIDOSIS ASSOCIATED WITH EMPAGLIFLOZIN THERAPY : MECHANISMS, RISC FACTORS AND CLINICAL IMPLICATIONS”. International journal of artificial intelligence 5, no. 09 (September 5, 2025): 221–223. Accessed March 15, 2026. https://www.academicpublishers.org/journals/index.php/ijai/article/view/6299.